Emergency pharmacy - xofigo (radium RA 223DICHLORIDE INJ) national drug code (NDC) 50419-0208-01
Ended Awarded Last action
- Contract number
- 36C26125N0262
- Awardee
-
Bayer Healthcare Pharmaceuticals Inc. UEI V1EVGCK7XES8 Part of Bayer Aktiengesellschaft
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $32,095
Award facts
- Contract value 100% obligated
- $32,094.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Whippany, Hanover, NJ 07981, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$67,077 | |
| Original award | $99,172 |
About this award
This is a federal delivery order contract awarded by the Department of Veterans Affairs (VA) to Bayer Healthcare Pharmaceuticals Inc., a subsidiary of the German pharmaceutical company Bayer AG. The contract is for the emergency supply of Xofigo (radium Ra 223 dichloride injection), a radiopharmaceutical used for the treatment of prostate cancer. The contract has a ceiling value of $32,094.82 and a completion date of January 9, 2025.
The contract is not designated as a small business set-aside and is issued under Bayer's existing $840 million multiple-award Federal Supply Schedule (FSS-61-IB) for Pharmaceuticals and Drugs with the VA. This allows various federal agencies to issue delivery orders for a wide range of pharmaceutical products. Bayer also holds an additional $45 million Blanket Purchase Agreement (BPA) with the VA specifically for Xofigo and Adempas medications. These pre-existing contract vehicles facilitate rapid procurement of essential medications for VA and other federal healthcare programs.
Quick answers
Who was awarded contract 36C26125N0262?
36C26125N0262 was awarded to Bayer Healthcare Pharmaceuticals Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on December 9, 2024.
How much is contract 36C26125N0262 worth?
The government has obligated $32,095 on 36C26125N0262.
Is contract 36C26125N0262 an order under another contract?
Yes. 36C26125N0262 is a delivery order under 36F79720D0237, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26125N0262 competed?
The extent of competition for 36C26125N0262 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award